Relapesed/Refractory (MAGNIFY)

Study Information

Status: Active, Not Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

East Bay

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

A Phase 3B Randomized Study of Lenalidomide (CC-5013) Plus Rituximab Maintenance Therapy Followed by Lenalidomide Single-Agent Maintenance Versus Rituximab in Subjects With Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma.

Location: REDI (East Bay)

Please contact Vivian Leong LeongV@sutterhealth.org about MAGNIFY

Principal Investigator

Rajesh Behl, M.D.

Recruitment Information

Please note that trial statuses change frequently, for the most up to date information regarding REDI's enrolling studies; please contact the research department at 510-204-5571.

Funder

Celgene Corporation

The Sutter Health Network of Care

Expertise to fit your needs

Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.